Current Ratio
since 2005
Calculation
Eli Lilly & Co., current ratio, long-term trends, calculation
Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
---|---|---|---|---|---|
Dec 31, 2019 | 1.16 | = | 13,709,600 | ÷ | 11,775,200 |
Dec 31, 2018 | 1.73 | = | 20,549,600 | ÷ | 11,888,100 |
Dec 31, 2017 | 1.32 | = | 19,202,100 | ÷ | 14,535,900 |
Dec 31, 2016 | 1.37 | = | 15,101,400 | ÷ | 10,986,600 |
Dec 31, 2015 | 1.53 | = | 12,573,600 | ÷ | 8,229,600 |
Dec 31, 2014 | 1.09 | = | 12,179,800 | ÷ | 11,207,500 |
Dec 31, 2013 | 1.47 | = | 13,104,700 | ÷ | 8,916,600 |
Dec 31, 2012 | 1.55 | = | 13,038,700 | ÷ | 8,389,500 |
Dec 31, 2011 | 1.60 | = | 14,248,200 | ÷ | 8,930,900 |
Dec 31, 2010 | 2.09 | = | 14,840,000 | ÷ | 7,101,400 |
Dec 31, 2009 | 1.90 | = | 12,486,500 | ÷ | 6,568,100 |
Dec 31, 2008 | 0.95 | = | 12,453,300 | ÷ | 13,109,700 |
Dec 31, 2007 | 2.33 | = | 12,256,900 | ÷ | 5,268,300 |
Dec 31, 2006 | 1.91 | = | 9,694,400 | ÷ | 5,085,500 |
Dec 31, 2005 | 1.89 | = | 10,795,800 | ÷ | 5,716,300 |
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19), 10-K (filing date: 2013-02-21), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-02-22), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-01).
1 US$ in thousands
Comparison to Competitors
Eli Lilly & Co., current ratio, long-term trends, comparison to competitors
Eli Lilly & Co. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2019 | 1.16 | 1.44 | 3.18 | 1.44 | 1.60 | 3.10 | 6.69 | 1.26 | 1.24 | 0.88 | 3.67 | 3.61 | 2.63 |
Dec 31, 2018 | 1.73 | 1.62 | 0.98 | 2.79 | 1.61 | 3.38 | 2.49 | 1.47 | 1.17 | 1.57 | 4.47 | 3.43 | 3.60 |
Dec 31, 2017 | 1.32 | 2.26 | 1.28 | 5.49 | 1.55 | 2.74 | 3.99 | 1.41 | 1.33 | 1.35 | 3.82 | 3.28 | 3.85 |
Dec 31, 2016 | 1.37 | 4.02 | 1.65 | 4.11 | 1.55 | 2.22 | 3.29 | 2.47 | 1.78 | 1.25 | 2.56 | 2.31 | 3.03 |
Dec 31, 2015 | 1.53 | 1.54 | 1.50 | 4.44 | 1.30 | 2.50 | 3.43 | 2.17 | 1.55 | 1.49 | 3.59 | 2.78 | 2.15 |
Dec 31, 2014 | 1.09 | 1.45 | 1.41 | 4.95 | 1.73 | 3.07 | 2.62 | 2.36 | 1.77 | 2.67 | 3.31 | 4.20 | 3.19 |
Dec 31, 2013 | 1.47 | 2.02 | 2.59 | 3.44 | 1.52 | 1.15 | 5.02 | 2.20 | 2.00 | 2.41 | 6.01 | 3.99 | 2.37 |
Dec 31, 2012 | 1.55 | 2.36 | 2.27 | 3.81 | 1.15 | 1.44 | 5.87 | 1.90 | 1.90 | 2.15 | 7.37 | 3.67 | 2.55 |
Dec 31, 2011 | 1.60 | 1.54 | — | 4.80 | 1.97 | 5.53 | 6.50 | 2.38 | 2.04 | 2.06 | 4.40 | 3.39 | — |
Dec 31, 2010 | 2.09 | 1.29 | — | 3.52 | 1.97 | 2.32 | 2.35 | 2.05 | 1.86 | 2.11 | 3.28 | 2.23 | — |
Dec 31, 2009 | 1.90 | 1.79 | — | 4.89 | 2.21 | 2.57 | 2.22 | 1.82 | 1.80 | 1.66 | 4.55 | 4.59 | — |
Dec 31, 2008 | 0.95 | 1.47 | — | 3.12 | 2.20 | 3.52 | 1.70 | 1.65 | 1.35 | 1.59 | 6.23 | 4.01 | — |
Dec 31, 2007 | 2.33 | 1.54 | — | 2.11 | 1.20 | 4.11 | 3.40 | 1.51 | 1.23 | 2.15 | 2.81 | 2.49 | — |
Dec 31, 2006 | 1.91 | 0.94 | — | 1.67 | 1.59 | 3.18 | 5.74 | 1.20 | 1.20 | 2.20 | 10.44 | 3.07 | — |
Dec 31, 2005 | 1.89 | 1.54 | — | 2.57 | 1.78 | 6.79 | 3.67 | 2.48 | 1.58 | 1.47 | 8.46 | 3.84 | — |
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19), 10-K (filing date: 2013-02-21), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-02-22), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-01).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Eli Lilly & Co., current ratio, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
Eli Lilly & Co. | Pharmaceuticals & Biotechnology | |
---|---|---|
Dec 31, 2019 | 1.16 | 1.57 |
Dec 31, 2018 | 1.73 | 1.73 |
Dec 31, 2017 | 1.32 | 1.82 |
Dec 31, 2016 | 1.37 | 2.10 |
Dec 31, 2015 | 1.53 | 1.93 |
Dec 31, 2014 | 1.09 | 2.20 |
Dec 31, 2013 | 1.47 | 2.15 |
Dec 31, 2012 | 1.55 | 2.09 |
Dec 31, 2011 | 1.60 | 2.25 |
Dec 31, 2010 | 2.09 | 2.01 |
Dec 31, 2009 | 1.90 | 1.92 |
Dec 31, 2008 | 0.95 | 1.62 |
Dec 31, 2007 | 2.33 | 1.73 |
Dec 31, 2006 | 1.91 | 1.55 |
Dec 31, 2005 | 1.89 | 1.81 |
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19), 10-K (filing date: 2013-02-21), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-02-22), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-01).
Comparison to Industry (Health Care)
Eli Lilly & Co., current ratio, long-term trends, comparison to industry (health care)
Eli Lilly & Co. | Health Care | |
---|---|---|
Dec 31, 2019 | 1.16 | 1.49 |
Dec 31, 2018 | 1.73 | 1.52 |
Dec 31, 2017 | 1.32 | 1.61 |
Dec 31, 2016 | 1.37 | 1.75 |
Dec 31, 2015 | 1.53 | 1.72 |
Dec 31, 2014 | 1.09 | 1.97 |
Dec 31, 2013 | 1.47 | 2.01 |
Dec 31, 2012 | 1.55 | 1.90 |
Dec 31, 2011 | 1.60 | 2.01 |
Dec 31, 2010 | 2.09 | 1.85 |
Dec 31, 2009 | 1.90 | 1.79 |
Dec 31, 2008 | 0.95 | 1.55 |
Dec 31, 2007 | 2.33 | 1.65 |
Dec 31, 2006 | 1.91 | 1.50 |
Dec 31, 2005 | 1.89 | 1.64 |
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19), 10-K (filing date: 2013-02-21), 10-K (filing date: 2012-02-24), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-02-22), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-02-28), 10-K (filing date: 2006-03-01).